Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kawasaki disease

S T Shulman1, J De Inocencio, R Hirsch

  • 1Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois, USA.

Pediatric Clinics of North America
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Echocardiography-derived septal curvature correlated with invasive hemodynamics in pediatric pulmonary hypertension.

Journal of echocardiography·2021
Same author

The Fontan Pathway: Change in Dimension and Catheter-Based Intervention over Time.

Pediatric cardiology·2021
Same author

Enhanced Quadrupole and Octupole Strength in Doubly Magic ^{132}Sn.

Physical review letters·2019
Same author

Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.

Clinical and experimental immunology·2017
Same author

The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults.

Bone marrow transplantation·2017
Same author

Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series.

Bone marrow transplantation·2016
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Kawasaki disease is a leading cause of acquired heart disease in children, significantly impacting cardiovascular health. This review emphasizes its immunologic aspects and current management challenges.

Area of Science:

  • Pediatrics
  • Immunology
  • Cardiology

Background:

  • Kawasaki disease is a critical pediatric illness.
  • It is the primary cause of acquired heart disease in children in developed nations.
  • Understanding its immunologic underpinnings is crucial for effective treatment.

Purpose of the Study:

  • To provide an updated review of Kawasaki disease.
  • To highlight the key immunologic aspects of the disease.
  • To discuss current challenges in managing this condition.

Main Methods:

  • Literature review of recent studies on Kawasaki disease.
  • Focus on research related to the immune system's role.
  • Synthesis of findings on epidemiology, clinical presentation, and treatment.

Related Experiment Videos

Main Results:

  • Kawasaki disease affects the cardiovascular system, leading to potential coronary artery aneurysms.
  • Immune system dysregulation, including cytokine storm and T-cell activation, is central to pathogenesis.
  • Current treatments aim to reduce inflammation and prevent cardiac complications.

Conclusions:

  • Kawasaki disease requires prompt diagnosis and treatment to mitigate long-term cardiac sequelae.
  • Further research into its immunologic mechanisms may reveal novel therapeutic targets.
  • Continued vigilance and updated management strategies are essential for pediatric populations.